---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-26-009659"
form_type: "8-K"
ticker: "NXL"
cik: "0001527352"
company_name: "Nexalin Technology, Inc."
filed_at: "2026-09-02T20:50:24+00:00"
generated_at: "2026-09-02T20:51:06.175594+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nexalin SVP Quality/Regulatory/Clinical Carolyn Shelton departs; separation terms set

## Summary
- Carolyn Shelton departed as SVP of Quality, Regulatory, and Clinical Affairs on Aug 28, 2026.
- Separation agreement includes one month of base salary and a $20,000 2026 bonus.
- Unvested stock options accelerated; vested options exercisable for up to two years.
- Health insurance premiums subsidized through Sept 30, 2026; includes release of claims and confidentiality/non-disparagement/cooperation.
- Agreement to be filed as exhibit to next periodic report.

## SEC filing metadata
- accession: 0001829126-26-009659
- form_type: 8-K
- ticker: NXL
- cik: 0001527352
- company_name: Nexalin Technology, Inc.
- filed_at: 2026-09-02T20:50:24+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1527352/000182912626009659/0001829126-26-009659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1527352/000182912626009659/nexalintec_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-26-009659
- JSON: https://secwatch.observer/filing/0001829126-26-009659.json
- Plain text: https://secwatch.observer/filing/0001829126-26-009659.txt

## Key facts
- Executive change
  Carolyn Shelton departed as Senior Vice President of Quality, Regulatory, and Clinical Affairs at Nexalin Technology, Inc..
  - Action: departed
  - Role: Senior Vice President of Quality, Regulatory, and Clinical Affairs
  source text: On August 28, 2026, Carolyn Shelton departed from her role as Senior Vice President of Quality, Regulatory, and Clinical Affairs of Nexalin Technology, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1527352/000182912626009659/0001829126-26-009659-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.